Artificial Intelligence
Artificial Intelligence (AI) in Drug Discovery Market Size, Share 2020-2027: Industry Analysis by CAGR of 40.5%, Growth & Opportunities, Upcoming Trends, Latest Innovation by Microsoft, IBM, NVIDIA, Cloud Pharmaceuticals
SAN FRANCISCO, Sept. 07, 2020 (GLOBE NEWSWIRE) — The “Artificial Intelligence (AI) in Drug Discovery Market Size“ Study has been added to DBMR database. This report consists of information about historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. This report also provides an overview of industry, future trends, size, share, key player’s analysis with respect to Artificial Intelligence (AI) in Drug Discovery market growth rate. This industry analysis report assists in determining and optimizing each stage in the lifecycle of industrial process that includes engagement, acquisition, retention, and monetization. The study envisage qualitative as well as quantitative market data and follows Industry benchmark classification and NAICS standards to build strong players coverage for final study. The study objectives are to present the Artificial Intelligence (AI) in Drug Discovery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe.
Artificial Intelligence (AI) in Drug Discovery Market is estimated to grow at a CAGR of 40.5% to an estimated value of USD 3,932.87 million by 2027 with factors such as lack of data sets and dearth of skilled labor will act as a restrain to the growth of the market in the forecast period of 2020 to 2027.
Download Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
Artificial Intelligence (AI) in Drug Discovery Market Scenario
According to Data Bridge Market Research the artificial intelligence (AI) in drug discovery market in developing regions is witnessing a growth in terms of its adoption rate, due to growth of pharmaceutical industries by collaborating with other industries and growing need to reduce drug discovery and cost along with lessen time. Postponement in patent expiry is also anticipated to enhance the growth of market. Furthermore, development of biotechnology industries will create new opportunities for the growth of the market.
The Artificial Intelligence (AI) in Drug Discovery Market report includes the market size, strategy, market orientation, expert opinion and knowledgeable information. The Artificial Intelligence (AI) in Drug Discovery Market Report is an in-depth study analyzing the current state of the Artificial Intelligence (AI) in Drug Discovery Market. Study on Artificial Intelligence (AI) in Drug Discovery Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.
The Prime Objective of Artificial Intelligence (AI) in Drug Discovery Market Report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 15 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
According to this report Global Artificial Intelligence (AI) in Drug Discovery Market will rise from Covid-19 crisis at moderate growth rate during 2020 to 2027. Artificial Intelligence (AI) in Drug Discovery Market includes comprehensive information derived from depth study on Artificial Intelligence (AI) in Drug Discovery Industry historical and forecast market data. Global Artificial Intelligence (AI) in Drug Discovery Market Size to Expand moderately as the new developments in Artificial Intelligence (AI) in Drug Discovery and Impact of COVID19 over the forecast period 2020 to 2027.
TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT–GET FREE COVID-19 SAMPLE @ https://www.databridgemarketresearch.com/covid-19-impact/global-artificial-intelligence-ai-in-drug-discovery-market
Artificial Intelligence (AI) in Drug Discovery Market report provides depth analysis of the market impact and new opportunities created by the COVID19/CORONA Virus pandemic. Report covers Artificial Intelligence (AI) in Drug Discovery Market report is helpful for strategists, marketers and senior management, And Key Players in Artificial Intelligence (AI) in Drug Discovery Industry.
The titled segments and sub-section of the market are illuminated below
- By Offering (Software, Services)
- By Technology (Machine Learning, Other Technologies)
- By Drug Type (Small Molecule, Large Molecules)
- By Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Other Applications)
- By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research Centres and Academic & Government Institutes)
Top Key Manufactures or Players (this may not be a complete list and extra companies can be added upon request):
- Microsoft
- NVIDIA Corporation
- IBM Corporation
- Atomwise, Inc
- DEEP GENOMICS
- Cloud Pharmaceuticals, Inc
- Insilico Medicine
- BenevolentAI Ltd
- Exscientia
- Cyclica Inc
- Numerate
- NuMedii, Inc
- Envisagenics
- twoXAR, Incorporated
- OWKIN, INC
- XtalPi Inc
- BERG LLC
Access Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-artificial-intelligence-ai-in-drug-discovery-market
Scope of Report:
The Market report lists the most important competitor’s and provides the insights strategic industry Analysis of the key factors influencing the market. This report will help you to establish a landscape of industrial development and characteristics of the Artificial Intelligence (AI) in Drug Discovery market. The Global Artificial Intelligence (AI) in Drug Discovery market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, price, cost, revenue and gross margins.
According to the Regional Segmentation the Main Bearing Market provides the Information covers following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.
For More Information or Query or Customization Before Buying, Visit @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
The data and the information regarding the Artificial Intelligence (AI) in Drug Discovery market growth are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts.
Global Artificial Intelligence (AI) in Drug Discovery Market Scope and Market Size
- Based on offering, artificial intelligence (AI) in drug discovery market is segmented into software and services.
- On the basis of technology, artificial intelligence (AI) in drug discovery market is segmented into machine learning and other technologies. Machine learning has been further segmented into deep learning, supervised learning, reinforcement learning, unsupervised learning and other machine learning technologies.
- Based on drug type, artificial intelligence (AI) in drug discovery market is segmented into small molecule and large molecules.
- On the basis of application, artificial intelligence (AI) in drug discovery market is segmented into immuno-oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases and other applications.
- Artificial intelligence (AI) in drug discovery market has also been segmented based on the end user into pharmaceutical & biotechnology companies, contract research organizations, research centres and academic & government institutes.
Major Objectives Covered in The Report:
A. The points that are discussed within the Artificial Intelligence (AI) in Drug Discovery Market report are the major market players that are involved in the market such as manufacturers, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
B. The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the Artificial Intelligence (AI) in Drug Discovery Market report. The historical data from 2010 to 2020 and forecast data from 2020 to 2027.
C. The growth factors of the Artificial Intelligence (AI) in Drug Discovery market are discussed in detail wherein the different end users of the market are explained in detail.
D. Data and information by manufacturer, by region, by type, by application and etc., and custom research can be added according to specific requirements.
E. The Artificial Intelligence (AI) in Drug Discovery market report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase: –
1) To gain insightful analyses of the keyword market and have comprehensive understanding of the global market and its commercial landscape.
2) Assess the production processes, major issues, and solutions to mitigate the development risk.
3) To understand the most affecting driving and restraining forces in the keyword market and its impact in the global market.
4) Learn about the keyword market strategies that are being adopted by leading respective organizations.
5) To understand the future outlook and prospects for the market.
6) Besides the standard structure reports, we also provide custom research according to specific requirements.
With tables and figures helping analyze worldwide Global Artificial Intelligence (AI) in Drug Discovery market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Strategic Points Covered in Table of Content of Global Artificial Intelligence (AI) in Drug Discovery Market:
- Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Global Artificial Intelligence (AI) in Drug Discovery market
- Chapter 2: Exclusive Summary – the basic information of the Global Artificial Intelligence (AI) in Drug Discovery Market.
- Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges of the Global Artificial Intelligence (AI) in Drug Discovery
- Chapter 4: Presenting the Global Artificial Intelligence (AI) in Drug Discovery Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
- Chapter 5: Displaying the by Type, End User and Region 2010-2020
- Chapter 6: Evaluating the leading manufacturers of the Global Artificial Intelligence (AI) in Drug Discovery market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
- Chapter 7: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.
- Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
- Finally, Global Artificial Intelligence (AI) in Drug Discovery Market is a valuable source of guidance for individuals and companies.
Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ https://www.databridgemarketresearch.com/toc/?dbmr=global-artificial-intelligence-ai-in-drug-discovery-market
Top Trending Related Reports
- Drug Discovery Informatics Market By Function (Sequencing & Target Data Analysis, Docking, Molecular Modelling, Libraries & Database Preparation, Other Functions), Solutions (Software, Services), End- User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Other End Users), Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics, Outsourced Informatics), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-drug-discovery-informatics-market
- Drug Discovery Outsourcing Market By Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow), Therapeutic Area (Respiratory System, Pain and Anaesthesia, Oncology, Ophthalmology, Haematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-Infective, Central Nervous System, Dermatology, Genitourinary System), Drug Type (Small Molecules, Large Molecules), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-drug-discovery-outsourcing-market
- Artificial intelligence in Healthcare Market By Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing, Context- Aware Computing, Computer Vision), Applications (Robot- Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis), End- Use Application (Patient Data and Risk Analysis, Inpatient Care & Hospital Management, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistant, Drug Discovery, Research, Healthcare Assistance Robots, Precision Medicine, Emergency Room & Surgery, Wearables, Mental Health), End- User (Hospitals and Providers, Patients, Pharmaceutical and Biotechnology Companies, Healthcare Payers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026 https://www.databridgemarketresearch.com/reports/global-artificial-intelligence-in-healthcare-market
- Mobile Artificial Intelligence (AI) Market, By Technology Type (7nm, 10nm, 20 To 28nm), Application (Drones, Smartphones, Cameras, Robotics, Smart Boards, AR/VR, Automotive And PCS ), Geographical Segments (North America, South America, Europe, Asia-Pacific, Middle East And Africa)-Industry Trends and Forecast to 2025 https://www.databridgemarketresearch.com/reports/global-mobile-artificial-intelligence-ai-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
E-Mail: [email protected]
Artificial Intelligence
Global Insurance Provider Selects 3CLogic to Streamline AI and Contact Center Capabilities with ServiceNow
Multinational Insurance Broker to deploy 3CLogic’s solution with ServiceNow’s Financial Service Operations (FSO) platform to streamline customer experiences.
ROCKVILLE, Md., April 25, 2024 /PRNewswire/ — 3CLogic, the leading Conversational AI and Contact Center solution for ServiceNow®, today announced its selection by a global insurance provider to replace its existing contact center infrastructure as part of a larger CX transformation effort. The strategic decision is designed to complement the organization’s use of ServiviceNow’s Financial Services Operations (FSO) offering leveraged across a number of its existing product lines including Customer Warranty Claims, Roadside Assistance, and Home Warranties.
Serving millions of customers worldwide with innovative insurance and protective products, the organization required a solution that would enhance its recent investment in the ServiceNow platform as it works to transform its end-to-end customer service operations. The deployment will incorporate several of 3CLogic’s AI-powered capabilities purpose-built for ServiceNow, including Conversational AI, Speech Analytics, and AI Performance & Coaching, along with integrated call transcriptions, convenient 2-way SMS, and ServiceNow-centralized contact center reporting.
“We continue to see enterprises eager to complement their existing investment in digital platforms, such as ServiceNow, with contact center features purpose-built to extend the workflows and features they already have and use,” explains Matt Durkin, VP of Global Sales at 3CLogic. “It’s no secret that organizations are already juggling too many systems, often with overlapping capabilities, which impacts ROI and operational efficiency. We’re proud to offer an alternative approach that helps simplify the technology stack while optimizing the overall operational costs and outcomes.”
Recently named to Constellation Research’s 2024 Shortlist for Digital Customer Service and Support, 3CLogic has seen global adoption of its solution by leading enterprises in healthcare, manufacturing, travel, retail, higher education, finance, non-profits, and Managed Service Providers across five continents. As a ServiceNow-certified Technology and Build partner with offerings available for ServiceNow’s IT Service Management, Customer Workflows, HR Service Delivery, and Source-to-Pay solutions, the company will be unveiling its latest set of capabilities at ServiceNow’s annual Knowledge 2024 event this May in Las Vegas.
For more information, please contact [email protected].
About 3CLogic3CLogic transforms customer and employee experiences with its leading Cloud Contact Center and AI solutions purpose-built to enhance today’s leading CRM and Customer Service Management platforms. Globally available and leveraged by the world’s leading brands, its offerings empower enterprise organizations with innovative features such as intelligent self-service, generative and Conversational AI, agent automation & coaching, and AI-powered sentiment analytics – all designed to lower operational costs, maximize ROI, and optimize each interaction across IT Service Desks, Customer Support, Sales or HR Services teams. For more information, please visit www.3clogic.com.
Logo – https://mma.prnewswire.com/media/2318845/3CLogic_logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-insurance-provider-selects-3clogic-to-streamline-ai-and-contact-center-capabilities-with-servicenow-302127739.html
Artificial Intelligence
ScreenPoint Medical Leadership Transition: Pieter Kroese Confirmed as CEO
Leading Breast AI Company, creator of industry-leading Transpara®, promotes from within for new CEO
NIJMEGEN, Netherlands, April 25, 2024 /PRNewswire/ — ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint’s commercial growth and success over the past 2 years.
The company’s Board of Directors has appointed Pieter Kroese as the new Chief Executive Officer effective April 25, 2024. Pieter takes the role after serving as COO of ScreenPoint for over five years. During that time, he has managed the transition of the company from an early startup to a thriving enterprise with hundreds of customers using ScreenPoint’s flagship Transpara software to support millions of scans a year.
“I am thrilled to lead ScreenPoint into its next phase of growth and innovation,” said Mr. Kroese. “I am deeply committed to building upon the strong foundation we have and continuing to work closely with our talented team to drive continued success. We are already expanding screening capacity and capability through proven reader support – we look forward to increasing our ability to support providers and women moving forward.”
Sir Michael Brady, Chairman of the Board at ScreenPoint Medical and a co-founder of the company, expressed enthusiasm about Pieter’s appointment, stating, “Pieter’s remarkable leadership qualities, coupled with his depth of knowledge of our product and industry, make him the perfect choice to lead ScreenPoint into the future. His strategic mindset and commitment to excellence align perfectly with our company mission of early breast cancer detection. Pieter has been an integral part of our growth to date and will provide seamless leadership through this transition into our next chapter for our customers, partners, and team.”
Author of “No Longer Radical” and over a hundred peer-reviewed publications on breast imaging, Dr. Rachel Brem is a Transpara user and ScreenPoint Board Member. Dr. Brem welcomed Mr. Kroese with the following: “Pieter has been an integral part of the ScreenPoint team for years. I am confident that his leadership will continue to deliver product excellence: earlier detection with outstanding reading workflow and improved patient outcomes. We continue to see these results from clinical sites all over the world, including many here in the United States. No other Breast AI solution has demonstrated the same results as Transpara, and I am confident that the team will continue to push on these frontiers under Pieter’s leadership.”
The entire team at ScreenPoint extends its gratitude to Mark Koeniguer and wishes him every success in the future, while warmly welcoming Pieter Kroese into his new role as CEO.
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers.
See all the proof at: https://screenpoint-medical.com/evidence.
Photo: https://mma.prnewswire.com/media/2397831/Pieter_Kroese_CEO_ScreenPoint_Medical.jpgLogo: https://mma.prnewswire.com/media/1582198/ScreenPoint_Medical_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/screenpoint-medical-leadership-transition-pieter-kroese-confirmed-as-ceo-302127719.html
Artificial Intelligence
Robotics Market to Surpass USD 126.96 Billion by 2031 | SkyQuest Technology
WESTFORD, Mass., April 25, 2024 /PRNewswire/ — The growing need for automation, technological developments, and long-term cost reductions are driving a robust expansion in the worldwide robotics market. SkyQuest projects that Global Robotics Market size is poised to grow from USD 41.50 Billion in 2023 to USD 126.96 Billion by 2031, at a CAGR of 15% during the forecast period (2024-2031).
Download a detailed overview:
https://www.skyquestt.com/report/robotics-market
Browse in-depth TOC on the “Robotics Market”
Pages – 202Tables – 64Figures – 75Robotics Market Overview:
Report Coverage
Details
Market Revenue in 2023
$41.50 billion
Estimated Value by 2031
$126.96 billion
Growth Rate
Poised to grow at a CAGR of 15%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Application, End Users, and Region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Collaborative Robotics
Key Market Opportunities
Prompting Several Industries to Adopt Automation Technologies
Key Market Drivers
Increasing Demand for Automation
Surge of Automation is Supporting Growth of Robotics Industry
The industrial sector is generating high revenues for the global robotics market owing to extensive automation in manufacturing, which increases productivity and lowers overall production costs. Assembly line, painting, and welding robots have become essential, thereby propelling substantial market expansion in the automotive, electronics, and heavy duty sectors. Due to the increased usage of robots for non-manufacturing functions such as customer service, shipping, and healthcare, the services sector is expanding quickly. This rapid growth is being driven by technological improvements and the push for automation in services.
Surge in Advance Robotics is Bolstering Market Growth
The use of robotics in manufacturing processes is growing, and innovation in this field is happening quickly worldwide. By increasing productivity, efficiency, and precision, advanced robotics technologies—such as AI-driven automation systems and collaborative robots, or cobots—are transforming the manufacturing sector. The dominance of manufacturing in the worldwide robotics market is fuelled by the integration of robotics into manufacturing facilities, which helps businesses remain competitive in today’s dynamic market scenario.
Rising Interest in Service Robotics is Driving Demand for Robotics in Asia Pacific
Due to the strong demand for industrial and service robots in the region, Asia Pacific now leads the global robotics industry. China, Japan, and South Korea are among the nations that have made significant investments in the robotics sector recently. The Middle East and Africa are anticipated to register the fastest-growing rate for the global robotics market. The expansion is ascribed to the region’s growing adoption of automation technology, especially in the manufacturing and logistics industries.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/robotics-market
Drivers:
Increasing Demand for AutomationAdvancements in AI and Machine Learning TechnologiesRestraints:
High Initial InvestmentsLack of Skilled WorkforceProminent Players in Global Robotics Market:
FANUC America Corporation (US)Epson Robotics (Japan)Staubli International AG (Switzerland)YRG Inc. (US)Comau S.p.A. (Italy)Northrop Grumman Corporation (US)Honda Motor Co., Ltd. (Japan)Seiko Epson Corporation (Japan)Yamaha Motor Co., Ltd. (Japan)Adept Technology, Inc. (US)View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/robotics-market
Key Questions Answered in Global Robotics Market Report
How big is the global robotics market, and what compound annual growth rate (CAGR) is it anticipated to deliver between 2024 and 2031?Which industries are fuelling the need for automation and fostering the expansion of the robotics sector?What impact have recent technological advancements and innovations had on the direction of the robotics market?Which well-known companies in the robotics industry are also major players in the global robotics market?This report provides the following insights:
Analysis of key drivers (increasing demand for automation across industries, improved the overall efficiency, productivity of the processes, demand for automation), restraints (high initial investments, difficult for small and medium-sized enterprises to invest, robots, sensors, and other equipment required not delivered), opportunities (advancements in AI and machine learning technologies, new opportunities for the robotics market, perform complex tasks with high accuracy), and challenges (lack of skilled workforce, maintenance of these robotics systems) influencing the growth of robotics marketMarket Penetration: Comprehensive information on the product portfolios offered by the top players in the robotics marketProduct Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the robotics marketMarket Development: Comprehensive information on lucrative emerging regionsMarket Diversification: Exhaustive information about new products, growing geographies, and recent developments in the marketCompetitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.Related Reports:
Global Service Robotics Market
Global Soft Robotics Market
Global Warehouse Robotics Market
Global Cloud Robotics Market
Global Robotic Welding Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:Mr. Jagraj SinghSkyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
View original content:https://www.prnewswire.co.uk/news-releases/robotics-market-to-surpass-usd-126-96-billion-by-2031–skyquest-technology-302127230.html
-
Uncategorized6 days ago
Generative AI gold rush drives IT spending — with payoff in question
-
Uncategorized6 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized6 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized6 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence6 days ago
Free Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized6 days ago
Can artificial intelligence reduce vehicle time to market?
-
Uncategorized6 days ago
The Ottawa Hospital doctors to try AI for patient notes
-
Artificial Intelligence5 days ago
Aurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions